4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-108233
President, CEO, and Chairman sold 57,969 shares at an average $4.04 ($234,155)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-09-17 | Sale 10b5-1 | −33,941 | $4.05 | $137,318 | 5,890,053 | I |
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-09-18 | Sale 10b5-1 | −22,187 | $4.03 | $89,469 | 5,867,866 | I |
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-09-19 | Sale 10b5-1 | −1,841 | $4.00 | $7,367 | 5,866,025 | I |
| Open-market sales · 57,969 sh · avg $4.04 · $234,155 | |||||||
Loading xslF345X05/ownership.xml…